• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA 在骨肉瘤进展、耐药性和预后中的多重功能。

The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis.

机构信息

Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Department of Gastroenterology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.

出版信息

Biomed Pharmacother. 2020 Jul;127:110141. doi: 10.1016/j.biopha.2020.110141. Epub 2020 Apr 22.

DOI:10.1016/j.biopha.2020.110141
PMID:32334375
Abstract

Osteosarcoma is a bone tumor prevalent in children and young adults. LncRNAs are a family of non-protein-coding transcripts longer than 200 nucleotides. The tumor-related pathological functions of lncRNAs include proliferation, migration, and chemotherapy resistance, all of which have been widely acknowledged in research on osteosarcoma. In addition, compelling evidence suggests that lncRNAs could serve as diagnostic indicators, prognostic biomarkers, and targets for disease treatment. In this review, we systematically summarize how lncRNAs regulate tumorigenesis, invasion and therapeutic resistance. By deepening our knowledge of the relationship between lncRNAs and osteosarcoma, we hope to translate research findings into clinical applications as soon as possible.

摘要

骨肉瘤是一种常见于儿童和青少年的骨肿瘤。长链非编码 RNA(lncRNA)是一类长度大于 200 个核苷酸的非蛋白编码转录本。lncRNA 的肿瘤相关病理功能包括增殖、迁移和化疗耐药等,这些在骨肉瘤的研究中已得到广泛认可。此外,大量证据表明,lncRNA 可以作为诊断指标、预后生物标志物和疾病治疗靶点。在这篇综述中,我们系统地总结了 lncRNA 如何调节肿瘤发生、侵袭和治疗耐药性。通过加深我们对 lncRNA 与骨肉瘤之间关系的认识,我们希望尽快将研究成果转化为临床应用。

相似文献

1
The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis.长非编码 RNA 在骨肉瘤进展、耐药性和预后中的多重功能。
Biomed Pharmacother. 2020 Jul;127:110141. doi: 10.1016/j.biopha.2020.110141. Epub 2020 Apr 22.
2
Long non-coding RNAs: emerging players in osteosarcoma.长链非编码RNA:骨肉瘤中的新兴角色
Tumour Biol. 2016 Mar;37(3):2811-6. doi: 10.1007/s13277-015-4749-4. Epub 2015 Dec 30.
3
Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma.长链非编码RNA在骨肉瘤进展、转移及预后中的作用
Cell Death Dis. 2016 Sep 29;7(9):e2389. doi: 10.1038/cddis.2016.272.
4
Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.长链非编码 RNA DBH-AS1 的下调通过 PI3K-AKT 信号通路抑制骨肉瘤的进展,并提示良好的预后。
Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1418-1427. doi: 10.26355/eurrev_201902_17098.
5
Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.长链非编码RNA在骨肉瘤中的应用:生物标志物与治疗靶点
Cell Physiol Biochem. 2017;42(4):1407-1419. doi: 10.1159/000479205. Epub 2017 Jul 17.
6
LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.长链非编码 RNA LINC00628 通过调控 PI3K/Akt 信号通路抑制骨肉瘤的生长和侵袭。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5857-5866. doi: 10.26355/eurrev_201809_15915.
7
Long noncoding RNAs in osteosarcoma via various signaling pathways.长链非编码 RNA 通过多种信号通路在骨肉瘤中的作用。
J Clin Lab Anal. 2020 Jun;34(6):e23317. doi: 10.1002/jcla.23317. Epub 2020 Apr 6.
8
Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.长链非编码 RNA OIP5-AS1 通过海绵吸附 miR-340-5p 诱导 LPAATβ/PI3K/AKT/mTOR 信号通路导致骨肉瘤顺铂耐药。
J Cell Biochem. 2019 Jun;120(6):9656-9666. doi: 10.1002/jcb.28244. Epub 2018 Dec 11.
9
Long non-coding RNAs in osteosarcoma.骨肉瘤中的长链非编码RNA
Oncotarget. 2017 Mar 21;8(12):20462-20475. doi: 10.18632/oncotarget.14726.
10
Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.长链非编码 RNA ITGB2-AS1 的下调通过抑制 Wnt/β-catenin 信号通路抑制骨肉瘤的增殖和转移,并预测良好的预后。
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S783-S790. doi: 10.1080/21691401.2018.1511576. Epub 2018 Sep 27.

引用本文的文献

1
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin.靶向RBM39可抑制肿瘤生长并使骨肉瘤细胞对顺铂敏感。
Oncogene. 2025 Mar;44(9):575-586. doi: 10.1038/s41388-024-03242-7. Epub 2024 Dec 4.
2
Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism.长链非编码RNA ARSR在肿瘤增殖、耐药性以及脂质和胆固醇代谢中的作用。
Clin Transl Oncol. 2025 Apr;27(4):1356-1365. doi: 10.1007/s12094-024-03700-4. Epub 2024 Sep 9.
3
LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review.
长链非编码RNA作为骨肉瘤潜在的预后/诊断标志物及导致耐药的因素:综述
Front Endocrinol (Lausanne). 2024 Jul 2;15:1415722. doi: 10.3389/fendo.2024.1415722. eCollection 2024.
4
Molecular insights into regulatory RNAs in the cellular machinery.分子层面解析细胞机制中的调控 RNA。
Exp Mol Med. 2024 Jun;56(6):1235-1249. doi: 10.1038/s12276-024-01239-6. Epub 2024 Jun 14.
5
LINC00467 induces melanoma deterioration by targeting miR-485-5p/p21 activated kinase 1.LINC00467通过靶向miR-485-5p/ p21激活激酶1诱导黑色素瘤恶化。
J Med Biochem. 2023 Mar 15;42(2):282-288. doi: 10.5937/jomb0-39708.
6
Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma.成骨肉瘤中上皮间质转化的调控。
Biomolecules. 2023 Feb 20;13(2):398. doi: 10.3390/biom13020398.
7
FLVCR1-AS1 and FBXL19-AS1: Two Putative lncRNA Candidates in Multiple Human Cancers.FLVCR1-AS1和FBXL19-AS1:人类多种癌症中两个潜在的长链非编码RNA候选物
Noncoding RNA. 2022 Dec 22;9(1):1. doi: 10.3390/ncrna9010001.
8
The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells.肿瘤微环境在调节骨肉瘤细胞可塑性中的作用。
Int J Mol Sci. 2022 Dec 18;23(24):16155. doi: 10.3390/ijms232416155.
9
Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells.肝素及基于肝素的药物递送系统:对骨肉瘤和免疫细胞多药耐药性的多效性分子效应
Pharmaceutics. 2022 Oct 13;14(10):2181. doi: 10.3390/pharmaceutics14102181.
10
Construction of a cuproptosis-related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients.构建铜死亡相关 lncRNA 特征模型预测骨肉瘤患者的预后和免疫图谱。
Cancer Med. 2023 Feb;12(4):5009-5024. doi: 10.1002/cam4.5214. Epub 2022 Sep 21.